Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q3 2019 · 10-Q
Revenue$0.00$0.00−100.0% vs Q3 2018 Net Income-$1.13M-$1.13MN/M vs Q3 2018 EPS Diluted$0.00$0.00— vs Q3 2018 Operating Income-$1,056,852N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$387,080N/M ended Sep 30, 2019 · filed Nov 13, 2019 · 44 d after period end